PODCAST

Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

health & fitness medicine

All Episodes

How AI Supports Rural Clinics in the Face of...

Empowered Patient Podcast ·

2026/01/14

Erez Druk, CEO of Freed, was motivated to bring technology to the healthcare environment based on his wife's experience as a family medicine doctor. Freed was founded to alleviate the provider's administrative burdens by leveraging AI to streamline pre-visit preparation, billing, and EHR maintenance. The focus is on small and rural private practices, giving them tools to save time, reduce costs, and maintain their independence. Erez explains, "So the need that I identified, together with my wife

21:15

How AI Supports Rural Clinics in the Face of...

Empowered Patient Podcast ·

2026/01/14

Hospital Real-Time Location Services Uncover Hidden...

Empowered Patient Podcast ·

2026/01/13

Mary Kelly Jagim, principal consultant at CenTrak, describes the role and benefits of real-time location services (RTLS) and how indoor GPS can improve facility management, patient safety, and staff morale. The use of RTLS in the development of smart hospitals helps mitigate staff burnout by reducing time-wasting tasks, such as searching for equipment, and by providing safety features like badge access and tracking. This technology is also being used to enhance the human touch in the clinical

16:20

Hospital Real-Time Location Services Uncover Hidden...

Empowered Patient Podcast ·

2026/01/13

Precision Drug Targets Specific Gene to Treat Bladder...

Empowered Patient Podcast ·

2026/01/12

Todd Harris, CEO and Co-Founder of Tyra Biosciences, is focused on developing a selective inhibitor for FGFR3, a protein implicated in bladder cancer and childhood dwarfism. The company has developed the SNAP discovery platform to accelerate structure-based drug design targeting this specific protein, while avoiding effects on related proteins to minimize significant side effects. Their lead drug candidate has the potential to become a primary well-tolerated oral monotherapy, shifting the treatment

17:30

Precision Drug Targets Specific Gene to Treat Bladder...

Empowered Patient Podcast ·

2026/01/12

Prioritizing Patient Access Means Focusing on the...

Empowered Patient Podcast ·

2026/01/12

Peyton Fry, Founder and owner of Glass Raven, discusses the complexities of patient access to healthcare and how healthcare systems often fall into the trap of measuring efficiency in ways that are financially beneficial for providers but are detrimental to patient care. Glass Raven helps organizations define key metrics of good patient access and the implementation of technology and AI to address the defined problems. This data-driven approach focuses on the populations most likely to benefit from

19:26

Prioritizing Patient Access Means Focusing on the...

Empowered Patient Podcast ·

2026/01/12

New Gut-Brain Signaling Drug Targets Prader-Willi...

Empowered Patient Podcast ·

2026/01/08

Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, draws a clear distinction between appetite and hunger and the implications for treating metabolic conditions and managing weight. The Aardvark lead drug candidate, an oral bitter taste receptor agonist designed to activate the gut-brain connection to turn off hunger, is showing effectiveness in treating Prader-Willi Syndrome and general obesity. There are also signs that this drug could be effective for those using GLP-1s to avoid nausea and

16:41

New Gut-Brain Signaling Drug Targets Prader-Willi...

Empowered Patient Podcast ·

2026/01/08

New Hepatitis B Oral Treatment Blocks Viral...

Empowered Patient Podcast ·

2026/01/07

Lawrence Blatt, Chairman, President, and CEO of Aligos Therapeutics, describes the current gaps in treating the hepatitis B virus and how the disease can potentially lead to end-stage liver disease and liver cancer. Current therapies were initially developed for HIV and can suppress the virus but not eliminate or prevent the disease. The lead Aligos drug candidate blocks all steps of viral replication and prevents the virus from integrating into infected liver cells, where it can activate

18:12

New Hepatitis B Oral Treatment Blocks Viral...

Empowered Patient Podcast ·

2026/01/07

Reality Check from Biotech Leaders on Using AI in...

Empowered Patient Podcast ·

2026/01/07

This roundtable on the role of AI in the biotech sector features Frank Yocca, Senior VP and Chief Scientific Officer at BioXcel Therapeutics, Joanne Taylor, Senior VP for Research at Gain Therapeutics, and Martin Brenner, CEO and Chief Scientific Officer at iBio. The conversation covers the historical adoption of AI in biotech, its current use in drug discovery, and future possibilities. AI is not a new phenomenon in biotech and has evolved from data processing to sophisticated models that can

47:29

Reality Check from Biotech Leaders on Using AI in...

Empowered Patient Podcast ·

2026/01/07

Developing Multi-Antigen Vaccines for...

Empowered Patient Podcast ·

2026/01/06

David Dodd, CEO of GeoVax, highlights the need for next-generation vaccines, specifically multi-antigen and T cell-focused technologies, to provide better protection for immunocompromised populations. Their pipeline includes a COVID-19 vaccine candidate, an Mpox/Smallpox vaccine, and a gene therapy for solid tumors. A priority for GeoVax is to develop new manufacturing processes to significantly accelerate vaccine production, increase yield, and reduce costs. David explains, "Multi-antigen

17:59

Developing Multi-Antigen Vaccines for...

Empowered Patient Podcast ·

2026/01/06

Virtual Support Groups Remove Barriers Encourage...

Empowered Patient Podcast ·

2025/12/18

Rick Davis, patient advocate and Founder of AnCan, is building and operating virtual peer-to-peer support groups to allow patients to connect with others who have direct experience with their condition. These groups can provide accurate information, foster connections among participants, and serve as a check on medical misinformation. With the growing acceptance of virtual meetings, this approach overcomes geographic, physical, and psychosocial barriers that might otherwise prevent participants

23:20

Virtual Support Groups Remove Barriers Encourage...

Empowered Patient Podcast ·

2025/12/18

Healthcare Plans Using Analytics to Improve Health...

Empowered Patient Podcast ·

2025/12/17

Bob Farrell, CEO of mPulse, is using digital technology, data analytics and AI to improve the relationship between health plans and their members in order to improve health outcomes and operational efficiency. Bob introduces the concept of HXI, Health Experience and Insights, as a framework that unites data, intelligence, and personalized communication to provide tools to enage members at the best time and by the preferred methods with appropriate information at the right time. Analyzing claims

19:48

Healthcare Plans Using Analytics to Improve Health...

Empowered Patient Podcast ·

2025/12/17

2,489 results

Empowered Patient Podcast

All Episodes

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown